Literature DB >> 17997698

Central pain syndrome: elucidation of genesis and treatment.

S Canavero1, V Bonicalzi.   

Abstract

Central pain (CP), namely, pain or allied symptoms that follow damage to the CNS, has remained an obscure neurological syndrome with no explanation or effective treatment since Edinger's description in 1891. Once believed to be rare, CP is now known to affect several millions of people worldwide, making it at least as frequent as, for example, Parkinson's disease. It follows such common entities as stroke, spinal cord injury and multiple sclerosis, but also many other conditions, including neurosurgical procedures on the brain and spine. A disturbance of thalamocortical transmission is now acknowledged to be the main engine of CP. When drugs fail, neuromodulation, both electrical and chemical, provide relief to many drug nonresponders. A small stereotactic lesion deep in the subparietal white matter promises complete relief, without the ravages of neuroablation as performed widely in the past.

Entities:  

Mesh:

Year:  2007        PMID: 17997698     DOI: 10.1586/14737175.7.11.1485

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  6 in total

1.  Brain stimulation for the treatment of pain: A review of costs, clinical effects, and mechanisms of treatment for three different central neuromodulatory approaches.

Authors:  Soroush Zaghi; Nikolas Heine; Felipe Fregni
Journal:  J Pain Manag       Date:  2009-08

2.  Biocompatibility of intracortical microelectrodes: current status and future prospects.

Authors:  Cristina Marin; Eduardo Fernández
Journal:  Front Neuroeng       Date:  2010-05-28

3.  Chronic pain following spinal cord injury.

Authors:  Radi Masri; Asaf Keller
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Thalamocortical asynchrony in conditions of spinal cord injury pain in rats.

Authors:  David A Seminowicz; Li Jiang; Yadong Ji; Su Xu; Rao P Gullapalli; Radi Masri
Journal:  J Neurosci       Date:  2012-11-07       Impact factor: 6.167

5.  Use of analgesics in acute stroke patients with inability to self-report pain: a retrospective cohort study.

Authors:  J Schuster; C Hoyer; A Ebert; A Alonso
Journal:  BMC Neurol       Date:  2020-01-14       Impact factor: 2.474

6.  Central Poststroke Pain: Its Profile among Stroke Survivors in Kano, Nigeria.

Authors:  Abdulbaki Halliru Bashir; Auwal Abdullahi; Muhammad Aliyu Abba; Naziru Bashir Mukhtar
Journal:  Behav Neurol       Date:  2017-09-19       Impact factor: 3.342

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.